Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Amplia Therapeutics Announces FDA Clearance Of IND For Pancreatic Cancer Trial In US

Jan 18 (Reuters) - Amplia Therapeutics Ltd  ATX.AX :
    * FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL
IN US

Source text for Eikon:  ID:nASX151FjF 
Further company coverage:  ATX.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Amplia Therapeutics

See all news